Terenac
Brand names,
Terenac
Analogs
Terenac
Brand Names Mixture
- For sope (sodium lauryl sulfate + stearic acid)
- Plax anti-plaque den rinse peppermint liq (sodium benzoate + sodium lauryl sulfate + sodium salicylate)
- Plax anti-plaque dent rinse soft mint liq (sodium benzoate + sodium lauryl sulfate + sodium salicylate)
- Plax anti-plaque dental rinse (sodium benzoate + sodium lauryl sulfate + sodium salicylate)
Terenac
Chemical_Formula
C15H22N2O
Terenac
RX_link
http://www.rxlist.com/cgi/generic2/mepivacaine.htm
Terenac
fda sheet
Terenac
msds (material safety sheet)
Terenac
Synthesis Reference
No information avaliable
Terenac
Molecular Weight
246.348 g/mol
Terenac
Melting Point
150.5 oC
Terenac
H2O Solubility
Soluble (7000 mg/L)
Terenac
State
Solid
Terenac
LogP
2.674
Terenac
Dosage Forms
Liquid; Solution
Terenac
Indication
For production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks.
Terenac
Pharmacology
Mepivicaine is a local anesthetic of the amide type. Mepivicaine as a reasonably rapid onset and medium duration and is known by the proprietary names as Carbocaine and Polocaine. Mepivicaine is used in local infiltration and regional anesthesia. Systemic absorption of local anesthetics produces effects on the cardiovascular and central nervous systems. At blood concentrations achieved with normal therapeutic doses, changes in cardiac conduction, excitability, refractoriness, contractility, and peripheral vascular resistance are minimal.
Terenac
Absorption
Absorbed locally. The rate of systemic absorption of local anesthetics is dependent upon the total dose and concentration of drug administered, the route of administration, the vascularity of the administration site, and the presence or absence of epinephrine in the anesthetic solution.
Terenac
side effects and Toxicity
The mean seizure dosage of mepivacaine in rhesus monkeys was found to be 18.8 mg/kg with mean arterial plasma concentration of 24.4 µg/mL. The intravenous and subcutaneous LD 50 in mice is 23 mg/kg to 35 mg/kg and 280 mg/kg respectively.
Terenac
Patient Information
Terenac
Organisms Affected
Humans and other mammals